Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV

Journal of Clinical Microbiology

Volumn 44, Issue 2, 2006, Pages 423-432

  Legoff, Jérôme ^a   Bouhlal, Hicham ^a   Grésenguet, Gérard ^b   Weiss, Helen ^c   Khonde, Nzambi ^d   Hocini, Hakim ^a   Désiré, Nathalie ^a   Si Mohamed, Ali ^a   De Dieu Longo, Jean ^b   Chemin, Cécile ^a   Frost, Eric ^e   Pépin, Jacques ^e   Malkin, Jean Elie ^f   Mayaud, Philippe ^b   Bélec, Laurent ^a,g  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre National de Reference des Maladies Sexuellement Transmissibles   (Central African Republic)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d West Africa Project to Combat AIDS   (Ghana)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f INSTITUT PASTEUR   (France)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; AFRICA; ARTICLE; AUTOMATION; CONTROLLED STUDY; COST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VIRUS IDENTIFICATION; VIRUS SHEDDING; VIRUS STRAIN;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CERVIX UTERI; DNA, VIRAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PROVIRUSES; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; VAGINA; VIRAL LOAD; VIRUS SHEDDING;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SIMPLEXVIRUS;

EID: 32344434639     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.2.423-432.2006     Document Type: Article

References (50)

1. Andreoletti, L., N. Chomont, G. Gresenguet, M. Matta, J. de Dieu Longo, M. P. Carreno, A. Si-Mohamed, J. Legoff, M. D. Kazatchkine, and L. Belec. 2003. Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women. J. Infect. Dis. 188:549-554.
2. Augenbraun, M., J. Feldman, K. Chirgwin, J. Zenilman, L. Clarke, J. DeHovitz, S. Landesman, and H. Minkoff. 1995. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann. Intern. Med. 123:845-847.
3. Baeten, J. M., R. S. McClelland, L. Corey, J. Overbaugh, L. Lavreys, B. A. Richardson, A. Wald, K. Mandaliya, J. J. Bwayo, and J. K. Kreiss. 2004. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial. J. Infect. Dis. 189:1466-1471.
4. Belec, L., D. Meillet, M. Levy, A. Georges, C. Tevi-Benissan, and J. Pillot. 1995. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin. Diagn. Lab. Immunol. 2:57-61.
5. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
6. Burrows, J., A. Nitsche, B. Bayly, E. Walker, G. Higgins, and T. Kok. 2002. Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol. 2:12.
7. Celum, C. L. 2004. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11(Suppl. 1):36A-45A.
8. Chomont, N., G. Gresenguet, M. Levy, H. Hocini, P. Becquart, M. Matta, J. Tranchot-Diallo, L. Andreoletti, M. P. Carreno, M. D. Kazatchkine, and L. Belec. 2001. Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women. Clin. Diagn. Lab. Immunol. 8:955-958.
9. Coombs, R. W., P. S. Reichelderfer, and A. L. Landay. 2003. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 17:455-480.
10. Corey, L., and H. H. Handsfield. 2000. Genital herpes and public health: addressing a global problem. JAMA 283:791-794.
11. Damond, F., D. Descamps, I. Farfara, J. N. Telles, S. Puyeo, P. Campa, A. Lepretre, S. Matheron, F. Brun-Vezinet, and F. Simon. 2001. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J. Clin. Microbiol. 39:4264-4268.
12. Desire, N., A. Dehee, V. Schneider, C. Jacomet, C. Goujon, P. M. Girard, W. Rozenbaum, and J. C. Nicolas. 2001. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 39:1303-1310.
13. DeVange Panteleeff, D., S. Emery, B. A. Richardson, C. Rousseau, S. Benki, S. Bodrug, J. K. Kreiss, and J. Overbaugh. 2002. Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J. Clin. Microbiol. 40:3929-3937.
14. Elbeik, T., W. G. Alvord, R. Trichavaroj, M. de Souza, R. Dewar, A. Brown, D. Chernoff, N. L. Michael, P. Nassos, K. Hadley, and V. L. Ng. 2002. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. J. Acquir. Immune Defic. Syndr. 29:330-339.
15. Erice, A., D. Brambilla, J. Bremer, J. B. Jackson, R. Kokka, B. Yen-Lieberman, and R. W. Coombs. 2000. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 38:2837-2845.
16. Filen, F., A. Strand, A. Allard, J. Blomberg, and B. Herrmann. 2004. Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex. Transm. Dis. 31:331-336.
17. Fischetti, L., O. Opare-Sem, D. Candotti, F. Sarkodie, H. Lee, and J. P. Allain. 2004. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J. Med. Virol. 73:158-166.
18. Hart, C. E., J. L. Lennox, M. Pratt-Palmore, T. C. Wright, R. F. Schinazi, T. Evans-Strickfaden, T. J. Bush, C. Schnell, L. J. Conley, K. A. Clancy, and T. V. Ellerbrock. 1999. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J. Infect. Dis. 179:871-882.
19. Hatzakis, A. E., G. Touloumi, N. Pantazis, C. G. Anastassopoulou, O. Katsarou, A. Karafoulidou, J. J. Goedert, and L. G. Kostrikis. 2004. Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS 18:2261-2267.
20. Hobson, A., A. Wald, N. Wright, and L. Corey. 1997. Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions. J. Clin. Microbiol. 35:548-552.
21. Izopet, J., G. Salama, C. Pasquier, K. Sandres, B. Marchou, P. Massip, and J. Puel. 1998. Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:478-483.
22. Kabamba-Mukadi, B., P. Henrivaux, J. Ruelle, N. Delferriere, M. Bodeus, and P. Goubau. 2005. Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR. BMC Infect. Dis. 5:15.
23. Kok, T., S. Wati, B. Bayly, D. Devonshire-Gill, and G. Higgins. 2000. Comparison of six nucleic acid extraction methods for detection of viral DNA or RNA sequences in four different non-serum specimen types. J. Clin. Virol. 16:59-63.
24. Korber, B., B. Hahn, B. Foley, J. W. Mellors, T. Leitner, G. Myers, F. McCutchan, and C. Kulken (ed.). 1997. HIV sequence compendium: human retroviruses and AIDS, 1997. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, N.Mex.
25. Kovacs, A., L. S. Chan, Z. C. Chen, W. A. Meyer III, L. Muderspach, M. Young, K. Anastos, and A. M. Levine. 1999. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J. Acquir. Immune Defic. Syndr. 22:124-131.
26. Kreiss, J. K., R. Coombs, F. Plummer, K. K. Holmes, B. Nikora, W. Cameron, E. Ngugi, J. O. Ndinya Achola, and L. Corey. 1989. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J. Infect. Dis. 160:380-384.
27. Larder, B., and C. Boucher. 1993. PCR detection of human immunodeficiency virus drug resistance mutations, p. 527-533. In D. H. Persing (ed.), Diagnostic molecular biology: principles and applications, vol. 1. American Society for Microbiology, Washington, D.C.
28. Laurendeau, I., M. Bahuau, N. Vodovar, C. Larramendy, M. Olivi, I. Bieche, M. Vidaud, and D. Vidaud. 1999. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin. Chem. 45:982-986.
29. Mackay, I. M., K. E. Arden, and A. Nitsche. 2002. Real-time PCR in virology. Nucleic Acids Res. 30:1292-1305.
30. Malkin, J. E. 2004. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(Suppl. 1):2A-23A.
31. Masquelier, B., E. Race, C. Tamalet, D. Descamps, J. Izopet, C. Buffet-Janvresse, A. Ruffault, A. S. Mohammed, J. Cottalorda, A. Schmuck, V. Calvez, E. Dam, H. Fleury, and F. Brun-Vezinet. 2001. Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors. Antimicrob. Agents Chemother. 45:1836-1842.
32. Mbopi-Keou, F. X., G. Gresenguet, P. Mayaud, H. A. Weiss, R. Gopal, M. Matta, J. L. Paul, D. W. Brown, R. J. Hayes, D. C. Mabey, and L. Belec. 2000. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J. Infect. Dis. 182:1090-1096.
33. Mbopi-Keou, F. X., J. Legoff, G. Gresenguet, A. Si-Mohamed, M. Matta, P. Mayaud, L. Andreoletti, J. E. Malkin, H. Weiss, D. Brown, and L. Belec. 2003. Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. J. Acquir. Immune Defic. Syndr. 33:121-124.
34. Mbopi-Keou, F. X., G. Gresenguet, P. Mayaud, H. A. Weiss, R. Gopal, D. W. Brown, R. J. Hayes, D. C. Mabey, and L. Belec. 1999. Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa. AIDS 13:536-537.
35. McClelland, R. S., C. C. Wang, J. Overbaugh, B. A. Richardson, L. Corey, R. L. Ashley, K. Mandaliya, J. Ndinya-Achola, J. J. Bwayo, and J. K. Kreiss. 2002. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 16:2425-2430.
36. Montavon, C., L. Vergne, A. Bourgeois, E. Mpoudi-Ngole, G. Malonga-Mouellet, C. Butel, C. Toure-Kane, E. Delaporte, and M. Peeters. 2002. Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res. Hum. Retrovir. 18:231-236.
37. Ndjoyi-Mbiguino, A., F. Ozouaki, J. Legoff, F. X. Mbopi-Keou, A. Si-Mohamed, I. N. Onas, E. Avoune, and L. Belec. 2003. Comparison of washing and swabbing procedures for collecting genital fluids to assess cervicovaginal shedding of herpes simplex virus type 2 DNA. J. Clin. Microbiol. 41:2662-2664.
38. Palmer, S., A. P. Wiegand, F. Maldarelli, H. Bazmi, J. M. Mican, M. Polis, R. L. Dewar, A. Planta, S. Liu, J. A. Metcalf, J. W. Mellors, and J. M. Coffin. 2003. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 41:4531-4536.
39. Rouet, F., D. K. Ekouevi, M. L. Chaix, M. Burgard, A. Inwoley, T. D. Tony, C. Danel, X. Anglaret, V. Leroy, P. Msellati, F. Dabis, and C. Rouzioux. 2005. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 Infection in a West African resource-limited setting. J. Clin. Microbiol. 43:2709-2717.
40. Ruelle, J., B. K. Mukadi, M. Schutten, and P. Goubau. 2004. Quantitative real-time PCR on Lightcycler for the detection of human immunodeficiency virus type 2 (HIV-2). J. Virol. Methods 117:67-74.
41. Ryncarz, A. J., J. Goddard, A. Wald, M. L. Huang, B. Roizman, and L. Corey. 1999. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J. Clin. Microbiol. 37:1941-1947.
42. Schacker, T., A. J. Ryncarz, J. Goddard, K. Diem, M. Shaughnessy, and L. Corey. 1998. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 280:61-66.
43. Si-Mohamed, A., L. Andreoletti, I. Colombet, M.-P. Carreno, G. Lopez, G. Chatelier, M. D. Kazatchkine, and L. Belec. 2001. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-1 MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0). J. Clin. Microbiol. 39:2055-2059.
44. Spinillo, A., F. Zara, B. Gardella, E. Preti, R. Mainini, and R. Maserati. 2005. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Am. J. Obstet. Gynecol. 192:774-779.
45. Swanson, P., V. Soriano, S. G. Devare, and J. Hackett, Jr. 2001. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J. Clin. Microbiol. 39:862-870.
46. Trouplin, V., F. Salvatori, F. Cappello, V. Obry, A. Brelot, N. Heveker, M. Alizon, G. Scarlatti, F. Clavel, and F. Mammano. 2001. Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J. Virol. 75:251-259.
47. Viard, J. P., M. Burgard, J. B. Hubert, L. Aaron, C. Rabian, N. Pertuiset, M. Lourenco, C. Rothschild, and C. Rouzioux. 2004. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 18:45-49.
48. Wald, A., and K. Link. 2002. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185:45-52.
49. Weiss, H. 2004. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11(Suppl, 1):24A-35A.
50. World Health Organization and UNAlDS. 2001. Herpes simplex virus type 2, Programmatic and research priorities in developing countries. World Health Organization, Geneva, Switzerland.